129 related articles for article (PubMed ID: 37357526)
21. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
22. A Mettl16/m
Han Y; Sun K; Yu S; Qin Y; Zhang Z; Luo J; Hu H; Dai L; Cui M; Jiang C; Liu F; Huang Y; Gao P; Chen X; Xin T; Ren X; Wu X; Song J; Wang Q; Tang Z; Chen J; Zhang H; Zhang X; Liu M; Luo D
EMBO J; 2024 May; 43(10):1990-2014. PubMed ID: 38605226
[TBL] [Abstract][Full Text] [Related]
23. METTL16-mediated translation of
Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
PeerJ; 2022; 10():e14379. PubMed ID: 36518278
[TBL] [Abstract][Full Text] [Related]
24. METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.
Xue M; Dong L; Zhang H; Li Y; Qiu K; Zhao Z; Gao M; Han L; Chan AKN; Li W; Leung K; Wang K; Pokharel SP; Qing Y; Liu W; Wang X; Ren L; Bi H; Yang L; Shen C; Chen Z; Melstrom L; Li H; Timchenko N; Deng X; Huang W; Rosen ST; Tian J; Xu L; Diao J; Chen CW; Chen J; Shen B; Chen H; Su R
J Hematol Oncol; 2024 Feb; 17(1):7. PubMed ID: 38302992
[TBL] [Abstract][Full Text] [Related]
25. The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.
Zhang Z; Xie Z; Lin J; Sun Z; Li Z; Yu W; Zeng Y; Ye G; Li J; Ye F; Su Z; Che Y; Xu P; Zeng C; Wang P; Wu Y; Shen H
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795489
[TBL] [Abstract][Full Text] [Related]
26. METTL16 exerts an m
Su R; Dong L; Li Y; Gao M; He PC; Liu W; Wei J; Zhao Z; Gao L; Han L; Deng X; Li C; Prince E; Tan B; Qing Y; Qin X; Shen C; Xue M; Zhou K; Chen Z; Xue J; Li W; Qin H; Wu X; Sun M; Nam Y; Chen CW; Huang W; Horne D; Rosen ST; He C; Chen J
Nat Cell Biol; 2022 Feb; 24(2):205-216. PubMed ID: 35145225
[TBL] [Abstract][Full Text] [Related]
27. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
29. Characterization of METTL16 as a cytoplasmic RNA binding protein.
Nance DJ; Satterwhite ER; Bhaskar B; Misra S; Carraway KR; Mansfield KD
PLoS One; 2020; 15(1):e0227647. PubMed ID: 31940410
[TBL] [Abstract][Full Text] [Related]
30. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
Deng R; Zhang J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
[TBL] [Abstract][Full Text] [Related]
31. VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
Chen Y; Liu Z; Wang H; Tang Z; Liu Y; Liang Z; Deng X; Zhao M; Fu Q; Li L; Cai H; Xie W; Fang W
Int J Cancer; 2020 Jan; 146(2):496-509. PubMed ID: 31125123
[TBL] [Abstract][Full Text] [Related]
32. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB
EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559
[TBL] [Abstract][Full Text] [Related]
33. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
[TBL] [Abstract][Full Text] [Related]
34. Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2.
Yu L; Lu J; Xie N; Fang L; Chen S; Wu Y; Wang X; Li B
J Cancer; 2023; 14(16):2964-2977. PubMed ID: 37859814
[TBL] [Abstract][Full Text] [Related]
35. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.
Cui Y; Dong YY
Aging (Albany NY); 2022 Sep; 14(18):7505-7516. PubMed ID: 36126191
[TBL] [Abstract][Full Text] [Related]
36. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
37. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
38. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
[TBL] [Abstract][Full Text] [Related]
40. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
